Gnosis by Lesaffre has announced a new brand identity for its vitamin K2 as MK-7 ingredient, MenaQ7, featuring a new logo and tagline.
Gnosis by Lesaffre has announced a new brand identity for its vitamin K2 as MK-7 ingredient, MenaQ7, featuring a new logo and tagline. The rebrand highlights Gnosis by Lesaffre’s efforts to explore the potential health benefits of vitamin K2 as MK-7 beyond its well-established and clinically validated benefits for bone health in children and cardiovascular health in adults. MenaQ7 has over 22 published human clinical trials supports its use.
“The foundation of clinical evidence using MenaQ7 is what built the Vitamin K2 category and shaped our understanding of this important nutrient as we know it today. We believe the brand has signified ‘Quality Confirmed by Science,’ which is why so many of our partners include the logo on their product labels, marketing collateral, and websites,” says Marc Philouze, Gnosis by Lesaffre general manager, in a press release. “Yet research is beckoning the continuation of that pioneering spirit, and more work must be done to confirm Vitamin K2’s expanding role in supporting other areas of health. To that end, we have decided to introduce a new logo and brand identity for this new journey.”
The new logo features a letter “Q” in the shape of a magnifying glass and the new tagline reads “Natural Vitamin K2 as MK-7.”
“The magnifying glass speaks to the curious spirit of discovery, and that quality and science must be meticulously sought,” says Philouze. “Curiosity is essential to usher Vitamin K2 into the future – illuminating new indications with technological innovations unlocking new consumer applications.”
According to Gnosis, the logo’s new colors and tagline emphasize that brand’s dedication to natural processes, leaving minimal environmental impact. Specifically, the colors have been softened and reversed from the traditional dark blue with light green accents to dark green and light blue accents.
“The visual identity introduced today has been designed to better connect with our customers and the industry, and represent the work we do, utilizing what nature has to offer and the protection of our planet’s resources,” Philouze concludes. “As we look to the future, we see nothing but promise and potential, particularly as the benefits of Vitamin K2 are expanding. Here, again, we will lead in that discovery with MenaQ7.”
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.